# Inventiva Pharma

**Canonical:** https://apis.io/providers/inventiva-pharma/  
**Website:** https://inventivapharma.com  
**APIs profiled:** 0

Inventiva Pharma develops differentiated treatments for Metabolic dysfunction-associated steatohepatitis (MASH), a progressive liver disease with cardiometabolic implications. Their lead candidate, lanifibranor, has FDA Breakthrough Therapy Designation and is in a global Phase 3 trial, aiming to restore metabolic balance and reduce inflammation and fibrosis. The company focuses on innovative oral therapies to address unmet needs in MASH patients.

## Kin Score — 5.9 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 46.4 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 10.5 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 9.8 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Inventiva Pharma Domain Security** — TLSv1.3 · DNSSEC · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, MASH, ClinicalTrials

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/inventiva-pharma/). Scores are computed from the provider's own public artifacts under a published rubric.